Ureteroscopy in 2012: The Scope of the Scope

  • Stephen Faddegon
  • Margaret S. PearleEmail author
Part of the Current Clinical Urology book series (CCU)


Ureteroscopy (URS) is an increasingly utilized treatment modality for a variety of upper urinary tract pathologies, including renal and ureteral calculi, ureteropelvic junction obstruction, ureteral strictures, and upper tract tumors. Although utilization patterns for the various treatment modalities can be extracted from billing records, case logs, and a variety of national datasets, the factors responsible for these practice patterns are not readily apparent from these data. The choice of treatment modality for upper tract pathology is complex, taking into account not only clinical outcomes but also patient and physician preferences, demographics of the community, and practice and economic factors. Although evidence-based clinical indications for URS should remain the focus for the practitioner, an awareness of these competing pressures may help the urologist avoid bias but also be cognizant of economic considerations in his/her choice of treatment modality.


Shock Wave Lithotripsy Renal Calculus Ureteral Calculus Ureteral Stricture Ureteropelvic Junction Obstruction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Zigeuner R, Pummer K. Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol. 2008;53:720–31.PubMedCrossRefGoogle Scholar
  2. 2.
    Yong D, Albala DM. Endopyelotomy in the age of laparoscopic and robotic-assisted pyeloplasty. Curr Urol Rep. 2010;11:74–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Krambeck AE, Murat FJ, Gettman MT, et al. The evolution of ureteroscopy: a modern single-institution series. Mayo Clin Proc. 2006;81:468–73.PubMedCrossRefGoogle Scholar
  4. 4.
    Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848–57.PubMedCrossRefGoogle Scholar
  5. 5.
    Kerbl K, Rehman J, Landman J, et al. Current management of urolithiasis: progress or regress? J Endourol. 2002;16:281–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Matlaga BR. Contemporary surgical management of upper urinary tract calculi. J Urol. 2009;181:2152–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Bandi G, Best SL, Nakada SY. Current practice patterns in the management of upper urinary tract calculi in the north central United States. J Endourol. 2008;22:631–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Scales Jr CD, Krupski TL, Curtis LH, et al. Practice variation in the surgical management of urinary lithiasis. J Urol. 2011;186:146–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Smith FL, Carper SW, Hall JS, et al. Cellular effects of piezoelectric versus electrohydraulic high energy shock waves. J Urol. 1992;147:486–90.PubMedGoogle Scholar
  10. 10.
    Razdan S, Johannes J, Cox M, et al. Current practice patterns in urologic management of upper-tract transitional-cell carcinoma. J Endourol. 2005;19:366–71.PubMedCrossRefGoogle Scholar
  11. 11.
    Tan BJ, Rastinehad AR, Marcovich R, et al. Trends in ureteropelvic junction obstruction management among urologists in the United States. Urology. 2005;65:260–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Gerber GS. Trends in endourologic practice. J Endourol. 2002;16:347–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Preminger GM, Tiselius HG, Assimos DG, et al. 2007 Guideline for the management of ureteral calculi. Eur Urol. 2007;52:1610–31.PubMedCrossRefGoogle Scholar
  14. 14.
    Fuchs M, Fuchs GJ. Retrograde intrarenal surgery for calculus disease: new minimally invasive treatment approach. J Endourol. 1990;4:337–41.Google Scholar
  15. 15.
    Fabrizio MD, Behari A, Bagley DH. Ureteroscopic management of intrarenal calculi. J Urol. 1998;159:1139–43.PubMedCrossRefGoogle Scholar
  16. 16.
    Grasso M. Ureteropyeloscopic treatment of ureteral and intrarenal calculi. Urol Clin North Am. 2000;27:623–31.PubMedCrossRefGoogle Scholar
  17. 17.
    Breda A, Ogunyemi O, Leppert JT, et al. Flexible ureteroscopy and laser lithotripsy for single intrarenal stones 2 cm or greater–is this the new frontier? J Urol. 2008;179:981–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Grasso M, Conlin M, Bagley D. Retrograde ureteropyeloscopic treatment of 2 cm. or greater upper urinary tract and minor Staghorn calculi. J Urol. 1998;160:346–51.PubMedCrossRefGoogle Scholar
  19. 19.
    Chung BI, Aron M, Hegarty NJ, et al. Ureteroscopic versus percutaneous treatment for medium-size (1–2-cm) renal calculi. J Endourol. 2008;22:343–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Pearle MS, Lingeman JE, Leveillee R, et al. Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol. 2005;173:2005–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Portis AJ, Rygwall R, Holtz C, et al. Ureteroscopic laser lithotripsy for upper urinary tract calculi with active fragment extraction and computerized tomography followup. J Urol. 2006;2006(175):2129–33. discussion 33–4.CrossRefGoogle Scholar
  22. 22.
    Macejko A, Okotie OT, Zhao LC, et al. Computed tomography-determined stone-free rates for ureteroscopy of upper-tract stones. J Endourol. 2009;23:379–82.PubMedCrossRefGoogle Scholar
  23. 23.
    L’Esperance JO, Ekeruo WO, Scales Jr CD, et al. Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi. Urology. 2005;66:252–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Schatloff O, Lindner U, Ramon J, et al. Randomized trial of stone fragment active retrieval versus spontaneous passage during holmium laser lithotripsy for ureteral stones. J Urol. 2010;183:1031–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Gravina GL, Costa AM, Ronchi P, et al. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology. 2005;66:24–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Zhu Y, Duijvesz D, Rovers MM, et al. Alpha-blockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis. BJU Int. 2010;106:256–61.PubMedCrossRefGoogle Scholar
  27. 27.
    John TT, Razdan S. Adjunctive tamsulosin improves stone free rate after ureteroscopic lithotripsy of large renal and ureteric calculi: a prospective randomized study. Urology. 2010;75:1040–2.PubMedCrossRefGoogle Scholar
  28. 28.
    Semins MJ, Trock BJ, Matlaga BR. The effect of shock wave rate on the outcome of shock wave lithotripsy: a meta-analysis. J Urol. 2008;179:194–7. discussion 97.PubMedCrossRefGoogle Scholar
  29. 29.
    Dash A, Schuster TG, Hollenbeck BK, et al. Ureteroscopic treatment of renal calculi in morbidly obese patients: a stone-matched comparison. Urology. 2002;60:393–7. discussion 97.PubMedCrossRefGoogle Scholar
  30. 30.
    Deem S, Defade B, Modak A, et al. Percutaneous nephrolithotomy versus extracorporeal shock wave lithotripsy for moderate sized kidney stones. Urology. 2011;78:739–43.PubMedCrossRefGoogle Scholar
  31. 31.
    Turna B, Stein RJ, Smaldone MC, et al. Safety and efficacy of flexible ureterorenoscopy and holmium:YAG lithotripsy for intrarenal stones in anticoagulated cases. J Urol. 2008;179:1415–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Wignall GR, Canales BK, Denstedt JD, et al. Minimally invasive approaches to upper urinary tract urolithiasis. Urol Clin North Am. 2008;35:441–54. viii.PubMedCrossRefGoogle Scholar
  33. 33.
    Ng CF. The effect of age on outcomes in patients undergoing treatment for renal stones. Curr Opin Urol. 2009;19:211–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Ng CF, Siu DY, Wong A, et al. Development of a scoring system from noncontrast computerized tomography measurements to improve the selection of upper ureteral stone for extracorporeal shock wave lithotripsy. J Urol. 2009;181:1151–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Perks AE, Schuler TD, Lee J, et al. Stone attenuation and skin-to-stone distance on computed tomography predicts for stone fragmentation by shock wave lithotripsy. Urology. 2008;72:765–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Wang LJ, Wong YC, Huang CC, et al. Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J Urol. 2010;183:48–55.PubMedCrossRefGoogle Scholar
  37. 37.
    Takahashi N, Kawashima A, Glockner JF, et al. MR urography for suspected upper tract urothelial carcinoma. Eur Radiol. 2009;19:912–23.PubMedCrossRefGoogle Scholar
  38. 38.
    Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584–94.PubMedCrossRefGoogle Scholar
  39. 39.
    Caraway NP, Katz RL. A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis. Cancer Cytopathol. 2010;118:175–83.PubMedCrossRefGoogle Scholar
  40. 40.
    Messer J, Shariat SF, Brien JC, et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int. 2011;108:701–5.PubMedGoogle Scholar
  41. 41.
    Mian C, Mazzoleni G, Vikoler S, et al. Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours. Eur Urol. 2010;58:288–92.PubMedCrossRefGoogle Scholar
  42. 42.
    El-Hakim A, Weiss GH, Lee BR, et al. Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma. Urology. 2004;63:647–50. discussion 50.PubMedCrossRefGoogle Scholar
  43. 43.
    Smith AK, Stephenson AJ, Lane BR, et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology. 2011;78:82–6.PubMedCrossRefGoogle Scholar
  44. 44.
    Matin SF, Kamat AM, Grossman HB. High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma: imaging findings and pathologic correlation. J Ultrasound Med. 2010;29:1277–84.PubMedGoogle Scholar
  45. 45.
    Traxer O, Geavlete B, de Medina SG, et al. Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience. J Endourol. 2011;25:19–23.PubMedCrossRefGoogle Scholar
  46. 46.
    Audenet F, Traxer O, Yates DR, et al. Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract. BJU Int. 2012;109(4):608–13.PubMedCrossRefGoogle Scholar
  47. 47.
    Favaretto RL, Shariat SF, Savage C, et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int. 2012;109:77–82.PubMedCrossRefGoogle Scholar
  48. 48.
    Jones JS, Streem SB. Office-based cystoureteroscopy for assessment of the upper urinary tract. J Endourol. 2002;16:307–9.PubMedCrossRefGoogle Scholar
  49. 49.
    Reisiger K, Hruby G, Clayman RV, et al. Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome. Urology. 2007;70:263–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Elliott DS, Segura JW, Lightner D, et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology. 2001;58:174–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Keeley Jr FX, Bibbo M, Bagley DH. Ureteroscopic treatment and surveillance of upper urinary tract transitional cell carcinoma. J Urol. 1997;157:1560–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Roupret M, Hupertan V, Traxer O, et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology. 2006;67:1181–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Daneshmand S, Quek ML, Huffman JL. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer. 2003;98:55–60.PubMedCrossRefGoogle Scholar
  54. 54.
    Martinez-Pineiro JA, Garcia Matres MJ, Martinez-Pineiro L. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol. 1996;156:377–85.PubMedCrossRefGoogle Scholar
  55. 55.
    Gurbuz C, Youssef RF, Shariat SF, et al. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol. 2011;25:775–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Krambeck AE, Thompson RH, Lohse CM, et al. Imperative indications for conservative management of upper tract transitional cell carcinoma. J Urol. 2007;178:792–6. discussion 96–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Kaag MG, O’Malley RL, O’Malley P, et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol. 2010;58:581–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Lane BR, Smith AK, Larson BT, et al. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer. 2010;116:2967–73.PubMedCrossRefGoogle Scholar
  59. 59.
    Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735–40.PubMedCrossRefGoogle Scholar
  60. 60.
    Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.PubMedCrossRefGoogle Scholar
  61. 61.
    Nahas AR, Shoma AM, Eraky I, et al. Prospective, randomized comparison of ureteroscopic endopyelotomy using holmium:YAG laser and balloon catheter. J Urol. 2006;175:614–8. discussion 18.PubMedCrossRefGoogle Scholar
  62. 62.
    Ost MC, Kaye JD, Guttman MJ, et al. Laparoscopic pyeloplasty versus antegrade endopyelotomy: comparison in 100 patients and a new algorithm for the minimally invasive treatment of ureteropelvic junction obstruction. Urology. 2005;66:47–51.PubMedCrossRefGoogle Scholar
  63. 63.
    Rassweiler JJ, Subotic S, Feist-Schwenk M, et al. Minimally invasive treatment of ureteropelvic junction obstruction: long-term experience with an algorithm for laser endopyelotomy and laparoscopic retroperitoneal pyeloplasty. J Urol. 2007;177:1000–5.PubMedCrossRefGoogle Scholar
  64. 64.
    Szydelko T, Kopec R, Kasprzak J, et al. Antegrade endopyelotomy versus laparoscopic pyeloplasty for primary ureteropelvic junction obstruction. J Laparoendosc Adv Surg Tech A. 2009;19:45–51.PubMedCrossRefGoogle Scholar
  65. 65.
    Dimarco DS, Gettman MT, McGee SM, et al. Long-term success of antegrade endopyelotomy compared with pyeloplasty at a single institution. J Endourol. 2006;20:707–12.PubMedCrossRefGoogle Scholar
  66. 66.
    Eden CG. Minimally invasive treatment of ureteropelvic junction obstruction: a critical analysis of results. Eur Urol. 2007;52:983–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Butani RP, Eshghi M. Cold-knife retrograde endopyelotomy: a long-term follow-up. J Endourol. 2008;22:657–60.PubMedCrossRefGoogle Scholar
  68. 68.
    Hafez KS, Wolf Jr JS. Update on minimally invasive management of ureteral strictures. J Endourol. 2003;17:453–64.PubMedCrossRefGoogle Scholar
  69. 69.
    Wolf Jr JS, Elashry OM, Clayman RV. Long-term results of endoureterotomy for benign ureteral and ureteroenteric strictures. J Urol. 1997;158:759–64.PubMedCrossRefGoogle Scholar
  70. 70.
    El-Nahas AR, Shokeir AA. Endourological treatment of nonmalignant upper urinary tract complications after urinary diversion. Urology. 2010;76:1302–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Watterson JD, Sofer M, Wollin TA, et al. Holmium: YAG laser endoureterotomy for ureterointestinal strictures. J Urol. 2002;167:1692–5.PubMedCrossRefGoogle Scholar
  72. 72.
    Bensalah K, Tuncel A, Gupta A, et al. Determinants of quality of life for patients with kidney stones. J Urol. 2008;179:2238–43. discussion 43.PubMedCrossRefGoogle Scholar
  73. 73.
    Marcovich R, Jacobson AI, Aldana JP, et al. Practice trends in contemporary management of adult ureteropelvic junction obstruction. Urology. 2003;62:22–5. discussion 25–6.PubMedCrossRefGoogle Scholar
  74. 74.
    Chandhoke PS. When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol. 2002;168:937–40.PubMedCrossRefGoogle Scholar
  75. 75.
    Lotan Y, Cadeddu JA, Roehrborn CG, et al. The value of your time: evaluation of effects of changes in medicare reimbursement rates on the practice of urology. J Urol. 2004;172:1958–62.PubMedCrossRefGoogle Scholar
  76. 76.
    Lotan Y, Gettman MT, Roehrborn CG, et al. Management of ureteral calculi: a cost comparison and decision making analysis. J Urol. 2002;167:1621–9.PubMedCrossRefGoogle Scholar
  77. 77.
    Lotan Y, Pearle MS. Economics of stone management. Urol Clin North Am. 2007;34:443–53.PubMedCrossRefGoogle Scholar
  78. 78.
    Tan HJ, Wolf Jr JS, Hollenbeck BK, et al. Use of ureteroscopy before and after expansion of lithotripter ownership in Michigan. Urology. 2011;78:1287–91.PubMedCrossRefGoogle Scholar
  79. 79.
    Hyams ES, Shah O. Percutaneous nephrostolithotomy versus flexible ureteroscopy/holmium laser lithotripsy: cost and outcome analysis. J Urol. 2009;182:1012–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Grasso M, Beaghler M, Loisides P. The case for primary endoscopic management of upper urinary tract calculi: II. Cost and outcome assessment of 112 primary ureteral calculi. Urology. 1995;45:372–6.PubMedCrossRefGoogle Scholar
  81. 81.
    Kapoor DA, Leech JE, Yap WT, et al. Cost and efficacy of extracorporeal shock wave lithotripsy versus ureteroscopy in the treatment of lower ureteral calculi. J Urol. 1992;148:1095–6.PubMedGoogle Scholar
  82. 82.
    Parker BD, Frederick RW, Reilly TP, et al. Efficiency and cost of treating proximal ureteral stones: shock wave lithotripsy versus ureteroscopy plus holmium:yttrium-aluminum-garnet laser. Urology. 2004;64:1102–6. discussion 06.PubMedCrossRefGoogle Scholar
  83. 83.
    Wolf Jr JS, Carroll PR, Stoller ML. Cost-effectiveness v patient preference in the choice of treatment for distal ureteral calculi: a literature-based decision analysis. J Endourol. 1995;9:243–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Litwin MS, Saigal CS (editors). Upper tract urothelial carcinoma. In: Urologic disease in America. Washington, DC: US Government Printing Office; 2007.Google Scholar
  85. 85.
    Pak RW, Moskowitz EJ, Bagley DH. What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. J Endourol. 2009;23:341–6.PubMedCrossRefGoogle Scholar
  86. 86.
    Gettman MT, Lotan Y, Roerhborn CG, et al. Cost-effective treatment for ureteropelvic junction obstruction: a decision tree analysis. J Urol. 2003;169:228–32.PubMedCrossRefGoogle Scholar
  87. 87.
    Baldwin DD, Dunbar JA, Wells N, et al. Single-center comparison of laparoscopic pyeloplasty, Acucise endopyelotomy, and open pyeloplasty. J Endourol. 2003;17:155–60.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of UrologyUT Southwestern Medical CenterDallasUSA

Personalised recommendations